AbbVie retains Humira market share above 70%: report
Source: SeekingAlpha
2025-01-16 11:27:08 ET
More on AbbVie
- AbbVie Inc. (ABBV) JPMorgan 43rd Annual Healthcare Conference (Transcript)
- AbbVie Has Immense Cash Flow Potential
- AbbVie's Stock Is Unfairly Cheap
- AbbVie may commit less capital to psych drugs: report
- AbbVie, AbCellera expand collaboration into T-cell engagers
Read the full article on Seeking Alpha
For further details see:
AbbVie retains Humira market share above 70%: report
Alvotech
NASDAQ: ALVO
ALVO Trading
-0.33% G/L:
$3 Last:
251,686 Volume:
$3 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
